The prognostic impact of preoperative and postoperative chemoradiation in clinical Stage II and III esophageal squamous cell carcinomas

Medicine (United States)

Volumn 94, Issue 25, 2015, Pages e1002-

  Chen, Hui Shan ^a   Wu, Shiao Chi ^a   Hsu, Po Kuei ^a,b   Huang, Chien Sheng ^a,b   Liu, Chia Chuan ^c   Wu, Yu Chung ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; SQUAMOUS CELL CARCINOMA; TAIWAN; TUMOR VOLUME; ADJUVANT CHEMORADIOTHERAPY; AGED; CARCINOMA, SQUAMOUS CELL; EPIDEMIOLOGY; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; TAIWAN;

EID: 84941212817     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001002     Document Type: Article

References (19)

1. Hsu PK, Wang BY, Huang CS, et al. Prognostic factors for postrecurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011; 15: 558-565.
2. Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013; 381: 400-412.
3. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003; 349: 2241-2252.
4. Hsu PK, Wu YC, Chou TY, et al. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-nodemetastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg. 2010; 89: 1024-1031.
5. Van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional Cancer. N Engl J Med. 2012; 366: 2074-2084.
6. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001; 19: 305-313.
7. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomized controlled phase III trial. Lancet Oncol. 2005; 6: 659-668.
8. Lee JL, Park SI, Kim S-B, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol. 2004; 15: 947-954.
9. Mariette C, Dahan L, Mornex F, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled Pphase III trial FFCD 9901. J Clin Oncol. 2014; 32: 2416-2422.
10. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med. 1997; 337: 161-167.
11. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodalityity therapy with cisplatin, uorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008; 26: 1086-1092.
12. Rice TW, Adelstein DJ, Chidel MA, et al. Benet of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg. 2003; 126: 1590-1596.
13. Bedard ELR, Inculet RI, Malthaner RA, et al. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer. 2001; 91: 2423-2430.
14. Hsu PK, Huang CS, Wang BY, et al. Survival benefits of postoperative chemoradiation in lymph node-positive esophageal squamous cell carcinoma. Ann Thorac Surg. 2014; 97: 1734-1741.
15. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997; 127: 757-763.
16. National Comprehensive Cancer Network. Esophageal cancer clinical practice guidelines in oncology. Available at: www.nccn.org. Accessed Dec. 2014
17. Parameswaran R, Titcomb DR, Blencowe NS, et al. Assessment and comparison of recovery after open and minimally invasive esophagectomy for cancer: an exploratory study in two centers. Ann Surg Oncol. 2013; 20: 1970-1977.
18. Hong JC, Murphy JD, Wang SJ, et al. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEERMedicare analysis. Ann Surg Oncol. 2013; 20: 3999-4007.
19. Lv J, Cao XF, Zhu B, et al. Long-Term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol. 2010; 16: 1649-1654.